EWA
PJP icon

EverSource Wealth Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

EverSource Wealth Advisors’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$311 Hold
3
– – ﹤0.01% 4135
2025
Q4 		$314 Buy
+3
New +$302 ﹤0.01% 3959

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

EverSource Wealth Advisors's PJP Position: Q1 2026 in Review

EverSource Wealth Advisors held its Invesco Pharmaceuticals ETF (PJP) position steady in Q1 2026 at 3 shares worth $311. The position accounts for ﹤0.01% of the portfolio, ranked #4135.

EverSource Wealth Advisors first reported a position in PJP in Q4 2025 and has held it in 2 quarters since. The position peaked at $314 in Q4 2025. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

  • EverSource Wealth Advisors held 3 shares of Invesco Pharmaceuticals ETF worth $311 as of Q1 2026.
  • EverSource Wealth Advisors left its Invesco Pharmaceuticals ETF share count unchanged in Q1 2026.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q1 2026, its #4135 holding.
  • EverSource Wealth Advisors first reported a position in Invesco Pharmaceuticals ETF in Q4 2025 and has held it in 2 quarters since.
  • EverSource Wealth Advisors's Invesco Pharmaceuticals ETF position peaked at $314 in Q4 2025.
  • 119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.